Sociedad Americana de Hirudoterapia

Chromosome-level genome assembly and anticoagulant protein annotation of the buffalo leech Hirudinaria bpling (Hirudinea: Hirudinidae)

Genome resource published in BMC Genomics (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genómica y proteómicaFarmacología salivalDesarrollo de fármacosKhan MS et al. · BMC genomics, 2025

Abstract

This study aimed to obtain and analyze the chromosome-level genome assembly of Hirudinaria bpling, a species vital for aquatic ecosystem health and medical research. Understanding its genomic information is crucial for advancing its medical applications and elucidating its ecological role. We assembled the genome of H. bpling using a combination of PacBio HiFi long reads, Illumina sequencing, and Hi-C chromosome conformation capture techniques. This approach allowed us to achieve a high-resolution genome assembly with detailed chromosomal organization. The final genome assembly of H. bpling is 144.08 Mb, with an N50 size of 11.27 Mb, anchored onto thirteen pseudo-chromosomes. BUSCO analysis indicated a genome completeness of 96.20%. We annotated a total of 20,126 protein-coding genes and identified 18.80% repetitive elements within the genome. Phylogenetic analysis included nine other leech species, positioning H. bpling as a sister taxon to Hirudo manillensis. A comparative analysis focused on the identification of putative anticoagulant proteins (e.g. Hirudin, Antistasin, Hirustasin, Therostasin, Bdellastasin, Guamerin/Piguamerin, Gelin, Bplins, Saratin, Eglin C, Bdellin B-3, LDTI, Hyaluronidase, Destabilase, Apyrase, Leech carboxypeptidase inhibitor, Gamma-glutamyl transpeptidase, Lefaxin, Progranulin), identifying conserved regions and evolutionary relationships among these proteins across different leech species. As a medically significant species, H. bpling offers promising opportunities for research into anticoagulant therapies. This study provides a comprehensive genomic and phylogenetic analysis of H. bpling, offering new insights into leech genomics and the evolution of anticoagulant genes. The findings enhance our understanding of the genetic and evolutionary mechanisms underlying anticoagulant production in leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsLeechesPhylogenyGenomeMolecular Sequence AnnotationAnticoagulantsChromosomesGenomics

Resumen

Chromosome-level genome assembly of Hirudinaria bpling (144 Mb, 13 pseudo-chromosomes, 96.20% BUSCO completeness, 20,126 protein-coding genes). Annotates ~20 anticoagulant protein families including hirudin, antistasin, hirustasin, therostasin, bdellastasin, gelin, eglin C, destabilase, hyaluronidase, and lefaxin.

Por qué esto importa para la hirudoterapia

This study produced a chromosome-level genome assembly of Hirudinaria bpling using PacBio HiFi, Illumina, and Hi-C data, achieving a 144.08 Mb genome with 96.20% BUSCO completeness, 20,126 protein-coding genes, 18.80% repetitive elements, and phylogenetic placement as sister taxon to Hirudo manillensis. The study computationally identified and comparatively analyzed putative anticoagulant proteins—including hirudin, antistasin, hirustasin, therostasin, bdellastasin, guamerin/piguamerin, gelin, bplins, saratin, eglin C, bdellin B-3, LDTI, hyaluronidase, destabilase, apyrase, and leech carboxypeptidase inhibitor—across leech species, and the abstract describes H. bpling as a medically significant species offering opportunities for anticoagulant therapy research. For ASH's domain, this is relevant as a genomic catalog of anticoagulant-related proteins from a leech with stated medical significance. However, this is a genome annotation study without functional validation or clinical data; therapeutic relevance is prospective and based on computational identification.

Citación

Chromosome-level genome assembly and anticoagulant protein annotation of the buffalo leech Hirudinaria bpling (Hirudinea: Hirudinidae).

Khan MS et al. · BMC genomics, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.